Persistent Systems Ltd (PERSISTENT) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- Persistent Systems reported healthy revenue growth of 19.9% year-on-year and 4.3% quarter-on-quarter, reaching US$360.2 million in Q3 FY25, marking the 19th consecutive quarter of sequential growth.
- The growth is net of furlough impact, with constant currency growth at 4.6% quarter-on-quarter.
- Healthcare and Life Sciences vertical crossed the $100 million quarterly revenue run rate.
- The company filed 20+ patents across various AI categories.
- The Board declared an interim dividend of Rs.20 per share.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.